ISSN: 1859 - 2872
Venous thromboembolism prophylaxis among hospitalized patients at University Medical Center Ho Chi Minh City
Main Article Content
Keywords
Abstract
Objective: To assess venous thromboembolism (VTE) prophylaxis at University Medical Center Hochiminh City (UMC HCMC). Subject and method: A cross-sectional study was carried out on 366 patients admitted to either Intensive Care Unit, Palliative Care Unit or Orthopedics and Traumatology Department at UMC HCMC from 02/2019 to 03/2019. Each patient was assessed VTE risk by PADUA scale, bleeding risk by IMPROVE scale, and identified an appropriate prophylaxis strategy using American College of Chest Physicians (ACCP) guideline for Antithrombotic Therapy and Prevention of Thrombosis 9th edition (2012) at the admission time and reassessed every 7 days. Result: Enoxaparin was the most common anticoagulant indicated for VTE. Of 581 assessments made, 62.1% were assessed as high-risk for VTE. The percentage of appropriate, underused, overused, and wrong prophylaxis indication were 59.5%, 33.4%, 1.4%, and 5.7%, respectively. Predominant inappropriate VTE prophylaxis indication included inaccurate risk stratification and incomplete adherence to guidelines. The risk of VTE, active cancer, respiratory diseases and musculoskeletal diseases were significantly associated with the overall appropriateness of VTE prophylaxis in the study population. Conclusion: Results from the study revealed the low rates of appropriateness in VTE prophylaxis at investigated wards. Underuse of prophylaxis, especially in medical wards must be taken into account in clinical practice.
Article Details
References
2. Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: The Padua Prediction Score. J Thomb Haemost 8(11): 2450-2457.
3. Byrne S, Weaver DT (2013) Review of thromboembolic prophylaxis in patients attending Cork University Hospital. Int J Clin Pharm 35(3): 439-446.
4. Cohen AT et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet. 371 (9610): 387-394.
5. Foster B et al (2014) Accuracy of the IMPROVE bleeding risk score for hospitalized medical patients. Chest 146(4): 823A.
6. Geldhof V et al (2014) Venous thromboembolism in the elderly: Efficacy and safety of non-VKA oral anticoagulants. Thrombosis Journal 12 (21).
7. Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(5): 1369.
8. Grant PJ et al (2018) Use of venous thromboembolism prophylaxis in hospitalized patients. JAMA Intern Med 178(8): 1122-1124.
9. Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2):195-226.
10. Manoucheri R et al (2015) Adherence to Venous thromboprophylaxis guidelines for medical and surgical inpatients of Teaching Hospitals, Shiraz-Iran. Tanaffos 14(1): 17-26.
11. Sharif-Kashani B et al (2012) Assessment of prophylaxis for venous thromboembolism in hospitalized patients: The MASIH Study. Clin Appl Thromb Hemost 18(5): 462-468.
12. Zhai Z et al (2019) VTE risk profiles and prophylaxis in medical and surgical Inpatients: The identification of Chinese hospitalized patients’ risk profile for venous thromboembolism (DissolVE-2) a cross-sectional study. Chest 155(1): 114-122.
Article Sidebar
